PD-L1 expression according to the EGFR status in primary lung adenocarcinoma-Reference-Cited by-同舟云学术

PD-L1 expression according to the EGFR status in primary lung adenocarcinoma

Published:2018-02 Issue: Volume:116 Page:1-6
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Takada Kazuki,Toyokawa Gouji,Tagawa Tetsuzo,Kohashi Kenichi,Shimokawa Mototsugu,Akamine Takaki,Takamori Shinkichi,Hirai Fumihiko,Shoji Fumihiro,Okamoto Tatsuro,Oda Yoshinao,Maehara Yoshihiko

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial;Rittmeyer;Lancet,2017

2. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung CancerPembrolizumab versus chemotherapy for PD-L1-Positive non-Small-Cell lung cancer;Reck;N. Engl. J. Med.,2016

3. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

4. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial;Fehrenbacher;Lancet,2016

5. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR Mutation and TKI Treatment Promote Secretion of Small Extracellular Vesicle PD-L1 and Contribute to Immunosuppression in NSCLC;Biomolecules;2024-07-09

2. Comparison of tissue biomarkers between non-schistosoma and schistosoma-associated urothelial carcinoma;Tissue and Cell;2024-06

3. CD155 Expression in Early-Stage Lung Adenocarcinoma;The Annals of Thoracic Surgery;2024-06

4. Durvalumab after chemoradiotherapy in non‐small cell lung cancer with EGFR mutation: A real‐world study (HOT2101);Cancer Science;2024-01-29

5. Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma;Anticancer Research;2023-11